Education
About Us
Working with TipRanks
Follow Us
Akero Therapeutics Inc (DE:0K4)
FRANKFURT:0K4
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -29.00K | $ -260.00K | $ -244.00K | $ -213.00K |
| Operating Income | $ -285.42M | $ -172.87M | $ -115.16M | $ -100.89M | $ -80.15M |
| EBITDA | $ -285.42M | $ -148.63M | $ -111.03M | $ -100.53M | $ -78.99M |
| Net Income | $ -252.06M | $ -151.76M | $ -108.91M | $ -100.74M | $ -79.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 743.08M | $ 550.01M | $ 351.45M | $ 188.26M | $ 268.39M |
| Total Assets | $ 825.89M | $ 580.27M | $ 356.57M | $ 195.55M | $ 273.34M |
| Total Debt | $ 529.00K | $ 26.30M | $ 10.95M | $ 1.52M | $ 1.81M |
| Net Debt | $ -339.71M | $ -207.90M | $ -238.83M | $ -148.97M | $ -185.43M |
| Total Liabilities | $ 75.77M | $ 44.97M | $ 30.01M | $ 26.44M | $ 14.63M |
| Stockholders' Equity | $ 750.11M | $ 535.31M | $ 326.56M | $ 169.11M | $ 258.71M |
| Cash Flow | |||||
| Free Cash Flow | $ -230.11M | $ -145.37M | $ -92.52M | $ -79.68M | $ -70.95M |
| Operating Cash Flow | $ -230.11M | $ -145.37M | $ -92.52M | $ -79.68M | $ -70.80M |
| Investing Cash Flow | $ -109.71M | $ -223.62M | $ -63.83M | $ 42.28M | $ -9.76M |
| Financing Cash Flow | $ 445.85M | $ 353.32M | $ 255.63M | $ 602.00K | $ 203.11M |